Potential virulence factors of Proteus bacilli

Microbiology and Molecular Biology Reviews

Volumn 61, Issue 1, 1997, Pages 65-89

  Rózalski, Antoni ^a   Sidorczyk, Zygmunt ^a   Kotełko, Krystyna ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; DEAMINASE; HEMAGGLUTININ; HEMOLYSIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; OUTER MEMBRANE PROTEIN; PROTEINASE; UREASE; VIRULENCE FACTOR;

BACTERIAL GROWTH; BACTERIAL VIRULENCE; FIMBRIA; FLAGELLUM; NONHUMAN; PROTEUS; PROTEUS MIRABILIS; PROTEUS VULGARIS; REVIEW;

BACILLI; BACTERIA (MICROORGANISMS); MIRABILIS; PROTEUS BACILLUS; PROTEUS MIRABILIS; PROTEUS PENNERI; PROTEUS VULGARIS;

EID: 0030791213     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/.61.1.65-89.1997     Document Type: Review

References (317)

1. Adegbola, R. A., D. C. Old, and B. W. Senior. 1983. The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for urinary tract. J. Med. Microbiol. 16:427-431.
2. Alberti, L., and R. M. Harshey. 1990. Differentiation of Serratia marcescens 274 into swimmer and swarmer cells. J. Bacteriol. 172:4322-4328.
3. Allison, C., N. Coleman, P. L. Jones, and C. Hughes. 1992. Ability of Proteus mirabilis to invade human urothelial cells is coupled to motility and swarming differentiation. Infect. Immun. 60:4740-4746.
4. Allison, C., L. Emödy, N. Coleman, and C. Hughes. 1994. The role of swarm cell differentiation and multicellular migration in the uropathogenicity of Proteus mirabilis. J. Infect. Dis. 169:1155-1158.
5. Allison, C., H. C. Lai, D. Gygi, and C. Hughes. 1993. Cell differentiation of Proteus mirabilis is initiated by glutamine, a specific chemoattractant for swarming cells. Mol. Microbiol. 8:53-60.
6. Allison, C., H. C. Lai, and C. Hughes. 1992. Co-ordinate expression of virulence genes during swarm-cell differentiation and population migration of Proteus mirabilis. Mol. Microbiol. 6:1583-1591.
7. Amano, K., M. Fujita, and T. Suto. 1993. Chemical properties of lipopolysaccharides from spotted fever group Rickettsiae and their common antigenicity with lipopolysaccharide from Proteus species. Infect. Immun. 61: 4350-4355.
8. Amano, K., H. Hatakayama, M. Okuta, T. Suto, and F. Mohara. 1992. Serological studies of antigenic similarity between Japanese spotted fever Rickettsiae and Weil-Felix test antigens. J. Clin. Microbiol. 30:2441-2446.
9. Amano, K., S. Mizushiri, S. Fuji, K. Fukushi, and T. Suto. 1990. Immunological characterization of lipopolysaccharides from Proteus strains used in Weil-Felix test and reactivity with patient sera of tsutsugamushi diseases. Microbiol. Immunol. 34:135-145.
10. Armitage, J. P., D. G. Smith, and R. J. Rowbury. 1979. Alteration in the cell envelope composition of Proteus mirabilis during development of swarmer cells. Biochim. Biophys. Acta 584:389-397.
11. Aronson, M., O. Medalia, L. Schori, D. Mirelman, N. Sharon, and I. Ofek. 1979. Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl-α-D-mannopyranoside. J. Infect. Dis. 139:329-332.
12. Bahrani, F. K., S. Cook, R. A. Hull, G. Massad, and H. L. T. Mobley. 1993. Proteus mirabilis fimbriae: N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequence of the genus from two strains. Infect. Immun. 61:884-891.
13. Bahrani, F. K., D. E. Johnson, D. Robbins, and H. L. T. Mobley. 1991. Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, N-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect. Immun. 59:3574-3580.
14. Bahrani, F. K., G. Massad, C. V. Lockatell, D. E. Johnson, R. G. Russel, J. W. Warren, and H. L. T. Mobley. 1994. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 62:3363-3371.
15. Bahrani, F. K., and H. L. T. Mobley. 1993. Proteus mirabilis MR/P fimbriae: molecular cloning, expression, and nucleotide sequence of the major fimbrial subunit gene. J. Bacteriol. 175:457-464.
16. Bahrani, F. K., and H. L. T. Mobley. 1994. Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression. J. Bacteriol. 176:3412-3419.
17. Bangert, R. L., A. C. S. Ward, E. H. Stauber, B. R. Cho, and P. R. Widders. 1988. A survey of the aerobic bacteria in the feces of captive raptors. Avian Dis. 32:53-62.
18. Bartodziejska, B., J. Radziejewska-Lebrecht, M. Lipińska, L. O. Kononov, A. Y. Chernyak, H. Mayer, and A. Różalski. 1996. Structural and immunochemical studies on lipopolysaccharide of the "T-antigen" containing mutant of P. mirabilis R14/1959. FEMS Immunol. Med. Microbiol. 13:113-121.
19. Bartodziejska, B., J. Radziejewska-Lebrecht, M. Lipińska, A. Ziółkowski, and A. Różalski. 1993. Epitope specificity of polyclonal antibodies against Proteus mirabilis R mutants. Med. Dośw. Mikrobiol. 45:99-102. (In Polish.)
20. Basu, S., J. Radziejewska-Lebrecht, and H. Mayer. 1986. Lipopolysaccharide of Providencia rettgeri. Chemical studies and taxonomical implications. Arch. Microbiol. 144:213-218.
21. Belas, R. 1992. The swarming phenomenon of Proteus mirabilis. ASM News 58:15-22.
22. Belas, R. 1994. Expression of multiple flagellin-encoding genes of Proteus mirabilis. J. Bacteriol. 176:7169-7181.
23. Belas, R. 1996. Proteus mirabilis swarmer cell differentiation and urinary tract infection, p. 271-298. In H. L. T. Mobley and J. W. Warren (ed.), Urinary tract infections. Molecular pathogenesis and clinical management. ASM Press, Washington, D.C.
24. Belas, R., D. Erskine, and D. Flaherty. 1991. Proteus mirabilis mutants defective in swarmer cell differentiation and multicellular behavior. J. Bacteriol. 173:6279-6288.
25. Belas, R., D. Erskine, and D. Flaherty. 1991. Transposon mutagenesis in Proteus mirabilis. J. Bacteriol. 173:6289-6293.
26. Belas, R., and D. Flaherty. 1994. Sequence and genetic analysis of multiple flagellin-encoding genes from Proteus mirabilis. Gene 148:33-41.
27. Belas, R., M. Goldman, and K. Ashliman. 1995. Genetic analysis of Proteus mirabilis mutants defective in swarm cell elongation. J. Bacteriol. 177:823-828.
28. Benz, R., K. R. Hardie, and C. Hughes. 1994. Pore formation in artificial membranes by the selected hemolysins of Proteus vulgaris and Morganella morganii. Eur. J. Biochem. 230:339-347.
29. Bergström, T. 1972. Sex differences in childhood urinary tract infection. Arch. Dis. Child. 47:227-232.
30. Berner, I., S. Konetschny-Rapp, G. Jung, and G. Winkelmann. 1988. Characterization of ferrioxamine E as the principal siderophore of Erwinia herbicide (Enterobacter agglomerans). Bio-Metals 1:51-56.
31. Bessler, W. G., and U. Henning. 1979. Protein I and protein II from the outer membrane of Escherichia coli are mouse β-lymphocyte mitogen. Z. Immunitätsforsch. 155:387-398.
32. Bessler, W. G., A. Lex, B. Suhr, A. Ortmann, S. Schlecht, H. Bühring, C. Müller, J. Metzger, K. H. Wiesmüller, and G. Jung. 1986. The synthetic analogs of bacterial lipoprotein are protect immunoadjuvants in combination with or covalently linked to antigen, p. 337-348. In J. Oppenheim and D. Jacobs (ed.), Leukocytes and host defense, vol. 5. Alan R. Liss, Inc., New York, N.Y.
33. Beynon, L. M., D. J. Dumanski, R. J. C. McLean, L. L. MacLean, J. C. Richards, and M. B. Perry. 1992. Capsule structure of Proteus mirabilis (ATCC 49565). J. Bacteriol. 174:2172-2177.
34. Bijlsma, I. G. W., L. van Dijk, J. G. Kusters, and W. Gaastra. 1995. Nucleotide sequence of two fimbrial major subunit genes, pmpA and ucaA from canine-uropathogenic Proteus mirabilis strains. Microbiology 141:1349-1357.
35. Boll, M., J. Radziejewska-Lebrecht, C. Warth, D. Krajewska-Pietrasik, and H. Mayer. 1994. 4-Amino-4-deoxy-L-arabinose in LPS of enterobacterial R mutants and its possible role for their polymyxin reactivity. FEMS Immunol. Med. Microbiol. 8:329-342.
36. Braude, A. J., and J. Siemienski. 1960. Role of bacterial urease in experimental pyelonephritis. J. Bacteriol. 80:171-179.
37. Braun, V., and T. Focareta. 1991. Pore-forming bacterial protein hemolysins (cytolysins). Crit. Rev. Microbiol. 18:115-158.
38. Breitenbach, J. M., and R. P. Hausinger. 1988. Proteus mirabilis urease partial purification and inhibition by boric acid and boronic acid. Biochem. J. 250:917-920.
39. Brenner, D. J., J. J. Farmer III, G. R. Fanning, A. G. Steigerwalt, P. Klykken, H. G. Wathert, F. W. Hickman, and H. W. Ewing. 1978. Deoxyribonucleic acid relatedness of Proteus and Providencia species. Int. J. Syst. Bacteriol. 28:269-282.
40. Brinton, C. C. 1965. The structure, function, synthesis and genetic control of bacterial pili and a molecular model of DNA and RNA transport in gram-negative bacteria. Trans. N. Y. Acad. Sci. 27:1003-1054.
41. Brubaker, R. R. 1985. Mechanisms of bacterial virulence. Annu. Rev. Microbiol. 39:21-50.
42. Bub, F., P. Bieker, H. H. Martin, and K. Nixdorff. 1980. Immunological characterization of two major proteins isolated from the outer membrane of Proteus mirabilis. Infect. Immun. 27:315-321.
43. 2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli. Infect. Immun. 62:259-265.
44. Cavaillon, J. M., and N. Haeffner-Cavaillon. 1986. Polymyxin B inhibition of LPS-induced interleukin-1 secretion by human monocytes is dependent on the LPS origin. Mol. Immun. 23:965-969.
45. Cedzyński, M., V. A. Knirel, A. Różalski, A. S. Shashkov, E. V. Vinogradov, and W. Kaca. 1995. The structure and serological specificity of Proteus mirabilis O43 O antigen. Eur. J. Biochem. 232:558-562.
46. Cedzyński, M., A. Różalski, K. Kotełko, W. Kaca, E. V. Vinogradov, Y. A. Knirel, and N. K. Kochetkov. 1993. Structural and immunological studies of Proteus mirabilis O33 of O-specific polysaccharide. Med. Dośw. Mikrobiol. 45:93-97. (In Polish.)
47. Cellini, L., R. Piccolomini, N. Allocati, and G. Ravagnan. 1987. Adhesive properties of Proteus genus related to antimicrobial agents resistance. Microbiologica 10:291-299.
48. Chang, C. C., and K. Merritt. 1991. Effect of Staphylococcus epidermidis on adherence of Pseudomonas aeruginosa and Proteus mirabilis to polymethyl metacrylate (PMMA) and gentamicin-containing PMMA. J. Orthop. Res. 9:284-288.
49. Chen, Y. H. U., R. E. W. Hancock, and R. I. Mishell. 1980. Mitogenic effect of purified outer membrane proteins from Pseudomonas aeruginosa. Infect. Immun. 27:178-184.
50. Cheng, K. J., R. T. Irwin, and J. W. Costerton. 1981. Autochthonous and pathogenic colonization of animal tissues by bacteria. Can. J. Microbiol. 27:461-490.
51. Chernyak, A. Y., L. O. Kononov, and N. K. Kochetkov. 1994. Glycopolymers from synthetic fragments (amides of α-D-galacturonic acid with amino acids) of Proteus O-antigens. J. Carbohydr. Chem. 13:386-396.
52. Chernyak, A. Y., L. O. Kononov, P. R. Krishna, N. K. Kochetkov, and A. V. R. Rao. 1992. Synthesis of lysine-containing fragments of Proteus mirabilis O27 O-specific polysaccharide and neoglycoconjugates therefrom. Carbohydr. Res. 225:279-289.
53. Cherry, W. B., P. L. Lentz, and L. A. Barnes. 1946. Implication of Proteus mirabilis in an outbreak of gastroenteritis. Am. J. Public Health 36:484-488.
54. Chippendale, G. R., J. W. Warren, A. L. Trifillis, and H. L. T. Mobley. 1994. Internalization of Proteus mirabilis by human renal epithelial cells. Infect. Immun. 62:3115-3121.
55. Chow, A. W., P. R. Taylor, T. T. Yoshikawa, and L. B. Guze. 1979. A nosocomial outbreak of infection due to multiply resistant Proteus mirabilis: role of intestinal colonization as a major reservoir. J. Infect. Dis. 130:621-627.
56. Clapham, L., R. J. C. McLean, J. C. Nickel, J. Downey, and J. W. Costerton. 1990. The influence of bacteria on struvite crystal habit and its importance in urinary stone formation. J. Crystal Growth 104:475-484.
57. Clegg, S., and G. F. Gerlach. 1987. Enterobacterial fimbriae. J. Bacteriol. 169:934-938.
58. Cook, S. W., N. Mody, J. Valle, and R. Hull. 1995. Molecular cloning of Proteus mirabilis uroepithelial cell adherence (uca) genes. Infect. Immun. 63:2082-2086.
59. Cooper, K. E., J. Davies, and J. Wieseman. 1971. An investigation of an outbreak of food poisoning associated with organisms of the Proteus group. J. Pathol. Bacteriol. 52:91-98.
60. Cosenza, B. J., and J. D. Podgwaite. 1966. A new species of Proteus isolated from the larvae of the gypsy moth Porthetria dispar (L). J. Microbiol. Serol. 32:187-191.
61. Costas, M., B. Holmes, K. A. Frith, C. Riddle, and P. M. Hawkey. 1993. Identification and typing of Proteus penneri and Proteus vulgaris biogroups 2 and 3, from clinical sources, by computerized analysis of electrophoretic protein patterns. J. Appl. Bacteriol. 75:489-498.
62. Coyne, C. P., and B. W. Fenwich. 1993. Inhibition of lipopolysaccharide-induced macrophage tumor necrosis factor α synthesis by polymyxin B sulfate. Am. J. Vet. Res. 54:305-314.
63. Datta, D. B., C. Krämer, and U. Henning. 1976. Diploidy for a structural gene specifying a major protein of the outer cell envelope membrane from Escherichia coli K-12. J. Bacteriol. 128:834-841.
64. Deighton, C. H., J. W. Gray, A. M. Bint, and D. J. Walker. 1992. Anti-Proteus antibodies in rheumatoid arthritis same-sexed sibships. Br. J. Rheumatol. 31:241-245.
65. Drechsel, H., A. Thicken, R. Reissbrodt, G. Jung, and G. Winkelmann. 1993. α-Keto acids are novel siderophores in the genera Proteus, Providencia, and Morganella and are produced by amino acid deaminases. J. Bacteriol. 175:2727-2733.
66. Duguid, J. P., and P. R. Gillies. 1957. Fimbrial and adhesive properties in dysentery bacilli. J. Pathol. Bacteriol. 74:397-411.
67. Duguid, J. P., and D. C. Old. 1980. Adhesive properties of Enterobacteriaceae, p. 185-217. In E. H. Beachey (ed.), Bacterial adherence. Receptors and recognition, ser. B, vol. 6. Chapman & Hall Ltd., London, United Kingdom.
68. Dumanski, A. J., H. Hedelin, A. Edin-Liljegren, D. Beauchemin, and R. J. C. McLean. 1994. Unique ability of the Proteus mirabilis capsule to enhance mineral growth in infectious urinary calculi. Infect. Immun. 62: 2998-3003.
69. Dutton, A. A. C., and M. Ralston. 1957. Urinary tract infection in a male urological ward with special reference to the mode of infection. Lancet i:115-119.
70. Ebringer, A., S. Khalafpour, and C. Wilson. 1989. Rheumathoid arthritis and Proteus: a possible aetiological association. Rheumatol. Int. 9:223-228.
71. Emödy, L., S. Vörös, and T. Pál. 1982. Alpha-hemolysin, a possible factor in Proteus morganii. FEMS Microbiol. Lett. 13:329-331.
72. Engler, H. D., K. Troy, and E. J. Bottone. 1990. Bacteremia and subcutaneous abscess caused by Proteus penneri in a neutropenic host. J. Clin. Microbiol. 28:1645-1646.
73. Evanylo, L. P., S. Kadis, and J. R. Maudsley. 1984. Siderophore production by Proteus mirabilis. Can. J. Microbiol. 30:1046-1051.
74. Farmer, J. J., III, B. R. Davis, F. W. Hickman-Brenner, A. Wharter, C. P. Huntley-Carter, M. A. Asbury, C. Ridle, H. G. Watheney-Grady, C. Elias, G. R. Fanning, A. G. Steigerwalt, C. M. O'Hara, G. K. Morris, P. B. Smith, and D. J. Brenner. 1985. Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens. J. Clin. Microbiol. 21:46-76.
75. Finlay, B. B. 1990. Cell adhesion and invasion mechanisms in microbial pathogenesis. Curr. Opin. Cell Biol. 2:815-820.
76. Finlay, B. B., and S. Falkow. 1989. Common themes in microbial pathogenicity. Microbiol. Rev. 53:210-230.
77. Fuksa, M., S. Krajden, and A. Lee. 1984. Susceptibility of 45 clinical isolates of Proteus penneri. Antimicrob. Agents Chemother. 26:419-420.
78. Gabidullin, Z. G., and I. B. Ishkildin. 1989. Morphological properties and adhesiveness of bacteria of the genus Proteus. J. Microbiol. Epidemiol. Immunol. 6:83-86.
79. Gaillard, L. J., B. Berche, C. Frehel, E. Gonin, and P. Cossart. 1991. Entry of L. monocytogenes into cells is mediated by internalin, a repeat protein reminiscent of surface antigens from gram-positive bacteria. Cell 65:1127-1141.
80. Gibson, F., and D. I. Magrath. 1969. The isolation and characterization of a hydroxamic acid (aerobactin) formed by Aerobacter aerogenes 62-1. Biochim. Biophys. Acta 192:175-184.
81. Gorvil, R. H. 1965. The fate of Pseudomonas aeruginosa, Proteus mirabilis and Escherichia coli in the mouse kidney. J. Pathol. Bacteriol. 89:81-88.
82. Graber, C. D., and A. F. Lincoln. 1955. Infantile diarrhoea in the Denver area: significance of the Proteus-Providencia organisms. Pediatrics 16:585-591.
83. Grace, M. E., F. J. Gregory, P. P. Hung, and K. P. Fu. 1986. Amplification and properties of a beta-lactamase from Proteus penneri. J. Antibiot. 39: 938-942.
84. Griffith, D. P., D. M. Musher, and C. Itin. 1976. Urease: the primary cause of infection-induced urinary stones. Invest. Urol. 13:346-350.
85. Gromska, W., W. Kaca, and K. Kotełko. 1978. The role of lysine in the serological specificity of some Proteus mirabilis lipopolysaccharides. Bull. Acad. Pol. Sci. Ser. Sci. Biol. 26:7-13.
86. Gromska, W., and H. Mayer. 1976. The linkage of lysine in the O-specific chains of Proteus mirabilis 1959. Eur. J. Biochem. 62:391-399.
87. Guentzel, M. N., and L. J. Berry. 1975. Motility as a virulence factor for Vibrio cholerae. Infect. Immun. 11:890-897.
88. Guo, M. M. S., and P. V. Lin. 1965. Serological specificities of ureases of Proteus species. J. Gen. Microbiol. 38:417-422.
89. Gygi, D., M. J. Bailey, C. Allison, and C. Hughes. 1995. Requirement for FlhA in flagella assembly and swarm-cell differentiation by Proteus mirabilis. Mol. Microbiol. 15:761-769.
90. Gygi, D., M. M. Rahman, H.-C. Lai, R. Carlson, J. Guard-Petter, and C. Hughes. 1995. A cell-surface polysaccharide that facilitates rapid population migration by differentiated swarm cell of Proteus mirabilis. Mol. Microbiol. 17:1167-1175.
91. Hacker, J., and W. Goebel. 1987. Mechanism and methods for analysing phatogenicity. Swiss Biotechnol. 5:21-31.
92. Hasin, M., S. Rottem, and S. Razin. 1975. The outer membrane of Proteus mirabilis. I. Isolation and characterization of the outer and cytoplasmic membrane fractions. Biochim. Biophys. Acta 375:381-394.
93. Hauser, G. 1885. Über Fäulnisbakterien und deren Beziehung zur Septicämia, p. 107. Vogel, Leipzig, Germany.
94. Hausinger, R. P. 1987. Nickel utilization by microorganisms. Microbiol. Rev. 51:22-42.
95. Hawkey, P. M., and C. A. Hawkey. 1984. Comparative in vitro activity of quinolone carboxylic acids against Proteus. J. Antimicrob. Chemother. 14: 485-489.
96. Hawkey, P. M., J. Haynes, J. Heritage, and L. Penner. 1986. Role of Proteeae in diarrheal disease. J. Clin. Microbiol. 24:504-505. (Letter.)
97. Hawkey, P. M., S. J. Pedler, and A. Turner. 1983. Comparative in vitro activity of semisynthetic penicillins against Proteeae. Antimicrob. Agents Chemother. 23:619-621.
98. Hawthorn, L., and G. Reid. 1990. The effect of protein and urine on uropathogen adhesion to polymer substrata. J. Biomed. Mater. Res. 24: 1325-1332.
99. Henriksen, J. 1972. Bacterial surface translocation: a survey and a classification. Bacteriol. Rev. 36:478-503.
100. Hickman, F. W., A. G. Steigerwalt, J. J. Farmer III, and D. J. Brenner. 1982. Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris biogroup 1. J. Clin. Microbiol. 15:1097-1102.
101. Hoffman, P., and W. G. Bessler. 1988. Tumor cytotoxicity involving TNF induced in bone marrow-derived macrophages by two lipopeptide analogues of bacterial lipoprotein. Immunobiology 178:94-101.
102. Hofstra, H., and J. Dankert. 1979. Antigenic cross-reactivity of major outer membrane proteins in Enterobacteriaceae species. J. Gen. Microbiol. 111: 293-302.
103. Hofstra, H., and J. Dankert. 1980. Antigenic cross-reactivity of outer membrane proteins of E. coli and Proteus species. FEMS Microbiol. Lett. 7:171-174.
104. Hofstra, H., M. J. D. Van Tol, and J. Dankert. 1980. Cross-reactivity of major outer membrane proteins of Enterobacteriaceae studied by crossed immunoelectrophoresis. J. Bacteriol. 143:328-337.
105. Holmes, B., M. Costas, and A. C. Wood. 1991. Typing of Proteus mirabilis from clinical sources by computerized analysis of electrophoretic protein patterns. J. Appl. Bacteriol. 71:467-476.
106. Hornick, D. B., B. L. Allen, M. A. Horn, and S. Clegg. 1991. Fimbrial types among respiratory isolates belonging to the family Enterobacteriaceae. J. Clin. Microbiol. 29:1795-1800.
107. Isberg, R. R., S. D. L. Voorhis, and S. Falkow. 1987. Identification of invasin: a protein that allows enteric bacteria to penetrate cultured mammalian cells. Cell 50:769-778.
108. Island, M. D., and H. L. T. Mobley. 1995. Proteus mirabilis urease: operon fusion and linker insertion analysis of ure gene organization, regulation, and function. J. Bacteriol. 177:5653-5660.
109. Johnson, D. E., R. G. Russell, C. V. Lockatell, J. C. Zulty, J. W. Warren, and H. L. T. Mobley. 1993. Contribution of Proteus mirabilis urease to persistent urolithiasis and acute pyelonephritis in a mouse model of ascending urinary tract infection. Infect. Immun. 61:2748-2754.
110. Johnson, J. R. 1991. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4:80-121.
111. Jones, B. D., C. V. Lockatell, D. E. Johnson, J. W. Warren, and H. L. T. Mobley. 1990. Construction of urease-negative mutant of Proteus mirabilis: analysis of virulence in a mouse model of ascending urinary tract infection. Infect. Immun. 58:1120-1123.
112. Jones, B. D., and H. L. T. Mobley. 1987. Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection. Infect. Immun. 55:2198-2203.
113. Jones, B. D., and H. L. T. Mobley. 1988. Proteus mirabilis urease: genetic organization, regulation, and expression of structural genes. J. Bacteriol. 170:3342-3349.
114. Jones, B. D., and H. L. T. Mobley. 1989. Proteus mirabilis urease: nucleotide sequence determination and comparison with Jack bean urease. J. Bacteriol. 171:6414-6422.
115. Kaca, W., and M. Cedzyński. Unpublished data.
116. Kaca, W., Y. A. Knirel, E. V. Vinogradov, and K. Kotełko. 1987. Structure of the O-specific polysaccharide of Proteus mirabilis S1959. Arch. Immunol. Ther. Exp. 35:431-437.
117. Kaca, W., and K. Kotełko. 1983. Lipopolysaccharide phage receptor of Proteus mirabilis 1959 strain. Site of phage mediated hydrolysis on O-specific polysaccharide. Arch. Immunol. Ther. Exp. 31:691-700.
118. Kaca, W., M. Mara, and J. Ocenaskova. 1996. Inhibition of mouse liver cytochrome P-450 by gram-negative bacteria lipopolysaccharides. Arch. Immunol. Ther. Exp. 44:39-44.
119. Kaca, W., J. Radziejewska-Lebrecht, and U. R. Bhat. 1990. Effect of polymyxins on the lipopolysaccharide defective mutants of P. mirabilis. Microbios 61:23-32.
120. Kaca, W., and R. I. Roth. 1995. Activation of complement by human hemoglobin and by mixtures of hemoglobin and bacterial endotoxin. Biochim. Biophys. Acta 1245:49-56.
121. Kaca, W., R. I. Roth, and J. Levin. 1994. Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J. Biol. Chem. 269:25078-25084.
122. Kaca, W., R. I. Roth, A. Ziółkowski, and J. Levin. 1994. Human hemoglobin increases the biological activity of bacterial lipopolysaccharides in activation of Limulus amebocyte lysate and stimulation of tissue factor production by endothelial cells in vitro. J. Endotoxin Res. 1:243-252.
123. Kaca, W., and A. Różalski. 1991. Characterization of cell-bound and cell-free hemolytic activity of Proteus strains. Eur. J. Epidemiol. 7:159-165.
124. Kappos, T., M. A. John, Z. Hussain, and M. A. Valvano. 1992. Outer membrane protein profiles and multilocus enzyme electrophoresis analysis for differentiation of clinical isolates of Proteus mirabilis and Proteus vulgaris. J. Clin. Microbiol. 30:2632-2637.
125. Karch, H., J. Gmeiner, and K. Nixdorff. 1983. Alteration of the immunoglobulin G subclass responses in mice to lipopolysaccharide effects of nonbacterial proteins and bacterial membrane phospholipids or outer membrane proteins of Proteus mirabilis. Infect. Immun. 40:157-165.
126. Karch, H., and K. Nixdorff. 1981. Antibody producing cell responses to an isolated outer membrane protein and to complexes of this antigen with lipopolysaccharide or with vesicles of phospholipids from Proteus mirabilis. Infect. Immun. 31:862-867.
127. Karch, H., and K. Nixdorff. 1983. Modulation of the IgG subclass responses to lipopolysaccharide by bacterial membrane components: differential adjuvant effects produced by primary and secondary stimulation. J. Immunol. 131:6-8.
128. Kauffmann, F. 1966. The bacteriology of Enterobacteriaceae, 3rd ed., p. 333. The Williams & Wilkins, Co., Baltimore, Md.
129. Kippax, P. W. 1957. A study of Proteus infections in a male urological ward. J. Clin. Pathol. 10:211-214.
130. Knirel, Y. A., N. A. Paramonov, E. V. Vinogradov, N. K. Kochetkov, Z. Sidorczyk, and K. Zych. 1994. 2-Acetamido-4-O-[(S)-1-carboxyethyl]-2-deoxy-D-glucose: a new natural isomer of N-acetylmuramic acid from the O-specific polysaccharide of Proteus penneri 35. Carbohydr. Res. 259:C1-C3.
131. Knirel, Y. A., N. A. Paramonov, E. V. Vinogradov, A. S. Shashkov, N. K. Kochetkov, Z. Sidorczyk, and A. Świerzko. 1992. Structure of the O-specific polysaccharide of Proteus penneri 62 containing 2-acetamido-3-O[(S)-1-carboxyethyl]-2-deoxy-D-glucose (N-acetylisomuramic acid). Carbohydr. Res. 235:C19-C23.
132. Knirel, Y. A., A. S. Shashkov, E. V. Vinogradov, A. Świerzko, and Z. Sidorczyk. 1995. The structure of the O-specific polysaccharide chain of Proteus penneri strain 42 lipopolysaccharide. Carbohydr. Res. 155:C1-C6.
133. Knirel, Y. A., E. V. Vinogradov, A. S. Shashkov, Z. Sidorczyk, W. Kaca, A. Różalski, K. Kotełko, and N. K. Kochetkov. 1992. Structure of Proteus O-specific polysaccharides. Dokl. Ross. Akad. Nauk 324:333-338. (In Russian.)
134. Knirel, Y. A., E. V. Vinogradov, A. S. Shashkov, Z. Sidorczyk, A. Różalski, J. Radziejewska-Lebrecht, and W. Kaca. 1993. Structural study of O-specific polysaccharides of Proteus. J. Carbohydr. Chem. 12:379-414.
135. Kornfeld, S. J., and A. G. Plant. 1981. Secretory immunity and the bacterial IgA proteases. Rev. Infect. Dis. 3:521-534.
136. Koronakis, V., M. Cross, B. Senior, E. Koronakis, and C. Hughes. 1987. The secreted hemolysins of Proteus mirabilis, Proteus vulgaris, and Morganella morganii are genetically related to each other and to the alpha-hemolysin of Escherichia coli. J. Bacteriol. 169:1509-1515.
137. Koronakis, V., and C. Hughes. 1988. Identification of the promoters directing in vivo expression of hemolysin genes in Proteus vulgaris and Escherichia coli. Mol. Gen. Genet. 213:99-104.
138. Koronakis, V., E. Koronakis, and C. Hughes. 1988. Comparison of the hemolysin secretion protein HlyB from Proteus vulgaris and Escherichia coli: site directed mutagenesis causing impairment of export function. Mol. Gen. Genet. 213:551-555.
139. Kotełko, K. 1986. Proteus mirabilis: taxonomic position, peculiarities of growth, components of the cell envelope. Curr. Top. Microbiol. Immunol. 129:181-215.
140. Kotełko, K., M. Deka, W. Gromska, W. Kaca, J. Radziejewska-Lebrecht, and A. Różalski. 1983. Galacturonic acid as the terminal constituent in the R-core polysaccharide of Proteus R110 (Ra) mutant. Arch. Immunol. Ther. Exp. 31:619-623.
141. Kotełko, K., W. Gromska, M. Papierz, Z. Sidorczyk, D. Krajewska, and K. Szer. 1977. Core region in Proteus mirabilis lipopolysaccharide. J. Hyg. Epidemiol. Microbiol. Immunol. 21:271-284.
142. Kotełko, K., W. Kaca, A. Różalski, and M. Deka. 1983. Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains. Acta Microbiol. Pol. 32:345-351.
143. Kotełko, K., A. Różalski, M. Deka, Z. Sidorczyk, W. Gromska, and K. Zych. 1983. Some biological features of Proteus bacilli. 1. Comparison of Proteus mirabilis strains provided from various sources. Acta Microbiol. Pol. 32: 334-339.
144. Krajden, S., M. Fuksa, W. Lizewski, L. Barton, and A. Lee. 1984. Proteus penneri and urinary calculi formation. J. Clin. Microbiol. 19:541-542.
145. Krajden, S., M. Fuksa, C. Petrea, L. J. Crisp, and J. L. Penner. 1987. Expanded clinical spectrum of infections caused by Proteus penneri. J. Clin. Microbiol. 25:578-579.
146. Krajewska-Pietrasik, D., A. Y. Chernyak, and A. Różalski. 1995. Use of synthetic antigens in studies of antigen specificity of Proteus mirabilis O27 lipopolysaccharide Med. Dośw. Mikrobiol. 47:169-176. (In Polish.)
147. Krajewska-Pietrasik, D., P. Larsson, K. Zych, J. Włodarczyk, and W. Gromska. 1991. Characteristics of spontaneously agglutinating Proteus mirabilis strains from bacteriuric patients. APMIS 99:956-960.
148. Krajewska-Pietrasik, D., A. Różalski, B. Bartodziejska, J. Radziejewska-Lebrecht, H. Mayer, and K. Kotełko. 1991. Properties of a deep Proteus R mutant isolated from clinical material. APMIS 99:499-506.
149. Lányi, B. 1956. Serological typing of Proteus strains from infantile enteritides and other sources. Acta Microbiol. Acad. Sci. Hung. 3:417-428.
150. Larsson, P. 1978. A comparison of the host-parasite relationship in urinary tract infections caused by Proteus and Escherichia coli in animals and children. Ph.D. thesis. University of Göteborg, Göteborg, Sweden.
151. Larsson, P. 1984. Serology of Proteus mirabilis and Proteus vulgaris. Methods Microbiol. 14:187-214.
152. Larsson, P., A. Fasth, U. Jodal, A. Sohl Akerlund, and C. Svanborg Eden. 1978. Urinary tract infections caused by Proteus mirabilis in children. The antibody response to O and H antigens and Tamm Horsfall protein and bacterial adherence to uroepithelium. Acta Paediatr. Scand. 67:591-596.
153. Larsson, P., and S. Olling. 1977. O-Antigen distribution and sensitivity to the bactericidal effect of normal human serum of Proteus strains from clinical specimens. Med. Microbiol. Immunol. 163:77-82.
154. Legnani-Fajardo, C., and P. Zunino. 1990. Antigenic and immunogenic activity of flagella and fimbriae of preparation from uropathogenic Proteus mirabilis. Can. J. Microbiol. 37:325-328.
155. Loomes, L. M., B. W. Senior, and M. A. Kerr. 1990. A proteolytic enzyme secreted by Proteus mirabilis degrades immunoglobulins of the immunoglobulin A1 (IgA1), IgA2, and IgG isotypes. Infect. Immun. 58:1979-1985.
156. Loomes, L. M., B. W. Senior, and M. A. Kerr. 1992. Proteinases of Proteus spp.: purification, properties, and detection in urine of infected patients. Infect. Immun. 60:2267-2273.
157. Lowell, G. H. 1990. Proteosomes, hydrophobic anchors, incoms and liposomes for improved presentation of peptide and protein vaccines, p. 141-160. In G. C. Woodrow and M. M. Levine (ed.), New generation of vaccines. Marcel Dekker, Inc., New York, N.Y.
158. Lugtenberg, B., H. Bronstein, N. Van Selm, and R. Peters. 1977. Peptidoglycan-associatcd outer membrane proteins in gram-negative bacteria. Biochim. Biophys. Acta 465:571-578.
159. Łukomski, S., B. Müller, and G. Schmidt. 1990. Extracellular hemolysin of Proteus penneri coded by chromosomal hly genes is similar to the α-hemolysin of Escherichia coli. Zentralbl. Bakteriol. 273:150-155.
160. Łukomski, S., M. Pytlos, L. Serwecińska, Z. Sidorczyk, and A. Jaworski. 1993. Analysis of antibiotic resistance determinants in Proteus penneri. Eur. J. Clin. Microbiol. Infect. Dis. 12:467-470.
161. Łukomski, S., L. Serwecińska, A. Różalski, J. Dziadek, P. Sta̧czek, and A. Jaworski. 1991. Cell-free and cell-bound hemolytic activities of Proteus penneri determination by different Hly determinants. Can. J. Microbiol. 37:419-424.
162. MacLaren, D. M. 1968. The significance of urease in Proteus pyelonephritis: a bacteriological study. J. Pathol. Bacteriol. 96:45-56.
163. MacLaren, D. M. 1969. The significance of urease in Proteus pyelonephritis a histological and biochemical study. J. Pathol. Bacteriol. 97:43-49.
164. Magana-Plaza, I., C. Montes, and J. Ruiz-Herrera. 1971. Purification and biochemical characteristics of urease from Proteus rettgeri. Biochim. Biophys. Acta 242:230-237.
165. Magana-Plaza, I., and J. Ruiz-Herrera. 1967. Mechanisms of regulation of urease biosynthesis in Proteus rettgeri. J. Bacteriol. 93:1294-1301.
166. Martin, M. A. 1991. Epidemiology and clinical impact of gram-negative sepsis. Infect. Dis. Clin. North Am. 5:739-752.
167. Massad, G., F. K. Bahrani, and H. L. T. Mobley. 1994. Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbria. Infect. Immun. 62:1989-1994.
168. Massad, G., C. V. Lockatell, D. E. Johnson, and H. L. T. Mobley. 1994. Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary tract infection. Infect. Immun. 62:536-542.
169. Massad, G., H. Zhao, and H. L. T. Mobley. 1995. Proteus mirabilis amino acid deaminase: cloning, nucleotide sequence, and characterization of aad. J. Bacteriol. 177:5878-5883.
170. McCarter, L., and M. Silverman. 1989. Iron regulation of swarmer cell differentiation of Vibrio parahaemolyticus. J. Bacteriol. 171:731-736.
171. McLean, R. J. C., K.-J. Cheng, W. D. Gould, and J. W. Costerton. 1986. Histochemical and biochemical urease localization in the periplasm and outer membrane of two Proteus mirabilis strains. Can. J. Microbiol. 32:772-778.
172. McLean, R. J. C., J. C. Nickel, K.-J. Cheng, and J. W. Costerton. 1988. The ecology and pathogenicity of urease-producing bacteria in the urinary tract. Crit. Rev. Microbiol. 16:37-79.
173. McLean, R. J. C., J. C. Nickel, V. C. Noakes, and J. W. Costerton. 1985. An in vitro ultrastructural study of infectious kidney stone genesis. Infect. Immun. 49:805-811.
174. McManus, A. T., E. E. Moody, and A. D. Mason. 1980. Bacterial motility: a component in experimental Pseudomonas aeruginosa burn wound sepsis. Burns 6:235-239.
175. Melchers, F., V. Braun, and C. Galanos. 1975. The lipoprotein of the outer membrane of Escherichia coli: a β-lymphocyte mitogen. J. Exp. Med. 142: 473-478.
176. Milazzo, F. H., and G. J. Delisle. 1984. Immunoglobulin A proteases in
177. Mizushiri, S., K. Amano, S. Fujii, K. Fukushi, and M. Watanabe. 1990. Chemical characterization of lipopolysaccharides from Proteus strains used in Weil-Felix test. Microbiol. Immunol. 34:121-133.
178. Moayeri, N., C. M. Collins, and P. O'Hanley. 1991. Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteas pyelonephritis in a BALB/c mouse model. Infect. Immun. 59:3778-3786.
179. Mobley, H. L. T. 1996. Virulence of Proteus mirabilis, p. 245-269. In H. L. T. Mobley and J. W. Warren (ed.), Urinary tract infections. Molecular pathogenesis and clinical management. ASM Press, Washington, D.C.
180. Mobley, H. L. T., and R. Belas. 1995. Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbiol. 3:280-284.
181. Mobley, H. L. T., and G. R. Chippendale. 1990. Hemagglutinin, urease and hemolysin production by Proteus mirabilis from clinical sources. J. Infect. Dis. 161:525-530.
182. Mobley, H. L. T., G. R. Chippendale, K. Swihart, and R. Welch. 1991. Cytotoxicity of the HpmA hemolysin and urease of Proteus mirabilis and Proteus vulgaris against cultured human renal proximal tubular cells. Infect. Immun. 59:2036-2042.
183. Mobley, H. L. T., G. R. Chippendale, J. H. Tenney, A. R. Mayer, L. J. Crisp, J. L. Penner, and J. W. Warren. 1988. MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria. J. Infect. Dis. 157:264-271.
184. Mobley, H. L. T., and R. P. Hausinger. 1989. Microbial ureases: significance, regulation, and molecular characterization. Microbiol. Rev. 53:85-108.
185. Mobley, H. L. T., M. D. Island, and R. P. Hausinger. 1995. Molecular biology of microbial ureases. Microbiol. Rev. 59:451-480.
186. Mobley, H. L. T., B. D. Jones, and A. E. Jerse. 1986. Cloning of urease gene sequence from Providencia stuartii. Infect. Immun. 54:161-169.
187. Mobley, H. L. T., B. D. Jones, and J. L. Penner. 1987. Urease activity of Proteus penneri. J. Clin. Microbiol. 25:2302-2305.
188. Mobley, H. L. T., and J. W. Warren. 1987. Urease-positive bacteriuria and obstruction of long-term urinary catheters. J. Clin. Microbiol. 25:2216-2217.
189. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharide. Immunochemistry 13:813-818.
190. Mörsdorf, G., and H. Kaltwasser. 1990. Cloning of the genes encoding urease from Proteus vulgaris and sequencing of the structural genes. FEMS Microbiol. Lett. 66:67-74.
191. Mortie, T. C., D. Doyle-Huntzinger, R. C. Craven, and I. A. Holder. 1982. Loss of virulence associated with absence of flagellum in an isogenic mutant of Pseudomonas aeruginosa in the burned-mouse model. Infect. Immun. 38:1296-1298.
192. Mulks, M. H. 1985. Microbial IgA proteases, p. 81-104. In I. A. Holder (ed.), Bacterial enzymes and virulence. CRC Press, Inc., Boca Raton, Fla.
193. Müller, H. E. 1986. Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces. J. Clin. Microbiol. 23:404-405.
194. Musher, D. M., D. P. Griffith, D. Yawn, and R. D. Rossen. 1975. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J. Infect. Dis. 131:177-181.
195. Nawrot, U., G. Mokracka-Latajka, J. Grzybek-Hryncewicz, B. Krzyżanowska, and S. Jankowski. 1995. Bactericidal activity of normal human serum against Morganella, Proteus and Providencia strains. Acta Microbiol. Pol. 44:55-61.
196. Nicholson, E. B., E. A. Concaugh, P. A. Foxall, M. D. Island, and H. L. T. Mobley. 1993. Proteus mirabilis urease transcriptional regulation by UreR. J. Bacteriol. 175:465-473.
197. Nicholson, E. B., E. A. Concaugh, and H. L. T. Mobley. 1991. Proteus mirabilis urease: use of a UreA-LacZ fusion demonstrates that induction is highly specific for urea. Infect. Immun. 59:3360-3365.
198. Nickel, J. C., J. Eutag, and J. W. Costerton. 1985. Ultrastructural microbial ecology of infection induced urinary stones. J. Urol. 133:622-627.
199. Nikaido, H., and M. Vaara. 1985. Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49:1-32.
200. Nixdorff, K., H. Fitzer, J. Gmeiner, and K. H. Martin. 1977. Reconstruction of model membranes from phospholipid and outer membrane proteins of Proteus mirabilis. Eur. J. Biochem. 81:63-69.
201. O'Brien, I. G., G. B. Cox, and F. Gibson. 1970. Biologically active compound containing 2,3,dihydroxybenzoic acid and serine formed by Escherichia coli. Biochim. Biophys. Acta 201:453-460.
202. Old, D. C., and R. Adegbola. 1982. Hemagglutinins and fimbriae of Morganella, Proteus and Providencia. J. Med. Microbiol. 15:551-564.
203. Old, D. C., and R. A. Adegbola. 1985. Antigenic relationships among type-3 fimbriae of Enterobacteriaceae revealed by immunoelectronmicroscopy. J. Med. Microbiol. 20:113-121.
204. Payne, S. M. 1988. Iron and virulence in the family Enterobacteriaceae. Crit. Rev. Microbiol. 16:81-111.
205. Peerbooms, P. G. H., A. M. J. J. Verweij, and P. M. MacLaren. 1982. Urinary virulence of Proteus mirabilis in two experimental mouse models. Infect. Immun. 36:1246-1248.
206. Peerbooms, P. G. M., A. M. J. J. Verweij, and D. M. MacLaren. 1983. Investigation of the haemolytic activity of Proteus mirabilis strains. Antonie Leeuwenhoek 49:1-11.
207. Peerbooms, P. G. M., A. M. J. J. Verweij, and D. M. MacLaren. 1984. Vero cell invasiveness of Proteus mirabilis. Infect. Immun. 43:1068-1071.
208. Peerbooms, P. G. M., A. M. J. J. Verweij, and D. M. MacLaren. 1985. Uropathogenic properties of Proteus mirabilis and Proteus vulgaris. J. Med. Microbiol. 19:55-60.
209. Penner, J. L. 1984. Genus XI. Proteus, p. 491-494. In N. R. Krieg and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. The Williams & Wilkins Co., Baltimore, Md.
210. Penner, J. L. 1992. The genera Proteus, Providencia and Morganella, p. 2849-2853. In A. Balows, H. G. Trüper, W. Harder, and K. H. Schleifer (ed.), The prokaryotes, vol. III. Springer-Verlag KG, Berlin, Germany.
211. Penner, J. L., and J. N. Hennessy. 1980. Separate O-grouping schemes for serotyping clinical isolates of Proteus vulgaris and Proteus mirabilis. J. Clin. Microbiol. 12:77-82.
212. Penner, J. L., N. A. Hinton, G. R. Whiteley, and J. N. Hennessy. 1976. Variation in urease activity of endemic hospital strains of Proteus rettgeri and Providencia stuartii. J. Infect. Dis. 134:370-376.
213. Perch, B. 1948. On the serology of the Proteus group. Acta Pathol. Microbiol. Scand. 25:703-714.
214. Perry, M. B., and L. L. MacLean. 1994. The structure of the polysaccharide produced by Proteus vulgaris (ATCC 49990). Carbohydr. Res. 253:257-263.
215. Philips, J. F. 1955. In vitro studies on Proteus organisms of animal origin. J. Hyg. 53:26-31.
216. Piccolomini, R., L. Cellini, N. Allocati, A. Di Girolamo, and G. Ravagnan. 1987. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. Antimicrob. Agents Chemother. 31:1644-1647.
217. Plant, A. G. 1983. The IgA1 proteases of pathogenic bacteria. Annu. Rev. Microbiol. 37:603-622.
218. Pollack, J. R., and J. B. Neilands. 1970. Enterobactin, an iron transport compound from Salmonella typhimurium. Biochem. Biophys. Res. Commun. 38:989-992.
219. Radziejewska-Lebrecht, J., U. R. Bhat, H. Brade, and H. Mayer. 1988. Structural studies on the core and lipid A region of a 4-amino-L-arabinose-lacking Rc type mutant of Proteus mirabilis. Eur. J. Biochem. 172:532-542.
220. Radziejewska-Lebrecht, J., U. Feige, M. Jensen, K. Kotełko, U. Friebolin, and H. Mayer. 1980. Structural studies on the glucose-heptose region of the Proteus mirabilis R core. Eur. J. Biochem. 107:31-38.
221. Radziejewska-Lebrecht, J., D. Krajewska-Pietrasik, and H. Mayer. 1990. Terminal and chain-linked residues of D-galacturonic acid: characteristic constituents of the R-core regions of Proteeae and Serratia marcescens. Syst. Appl. Microbiol. 13:214-219.
222. Radziejewska-Lebrecht, J., and H. Mayer. 1989. The core region of Proteus mirabilis R110/1959 lipopolysaccharide. Eur. J. Biochem. 183:573-581.
223. Radziejewska-Lebrecht, J., A. S. Shashkov, E. V. Vinogradov, U. Grosskurth, B. Bartodziejska, A. Różalski, W. Kaca, L. O. Kononov, A. Y. Chernyak, H. Mayer, Y. A. Knirel, and N. K. Kochetkov. 1995. Structure and epitope characterization of the O-specific polysaccharide of Proteus mirabilis O28 containing amides of D-galacturonic acid with L-serine and L-lysine. Eur. J. Biochem. 230:705-712.
224. Radziejewska-Lebrecht, J., K. Zych, M. Lipińska, and Z. Sidorczyk. 1993. Further core types of Proteus lipopolysaccharides. Med. Dośw. Mikrobiol. 45:65-68. (In Polish.)
225. Rando, D., U. Steglitz, G. Mörsdorf, and H. Kaltwasser. 1990. Nickel availability and urease expression in Proteus mirabilis. Arch. Microbiol. 154:428-432.
226. Raoult, D., and G. A. Dasch. 1995. Immunoblot cross-reactions among Rickettsia, Proteus sp. and Legionella sp. in patients with Mediterranean spotted fever. FEMS Immunol. Med. Microbiol. 11:13-18.
227. Reid, G., and J. D. Sobel. 1987. Bacterial adherence in the pathogenesis of urinary tract infections: a review. Rev. Infect. Dis. 9:470-487.
228. Reissbrodt, R., W. Rabsch, A. Chapeaurouge, G. Jung, and G. Winkelmann. 1990. Isolation and identification of ferroxamine G and E in Hafnia alvei. Bio-Metals 3:54-60.
229. Rietschel, E. T., and H. Brade. 1992. Bacterial endotoxins. Sci. Am. 267: 26-33.
230. Rietschel, E. T., L. Brade, B. Lindner, and U. Zähringer. 1992. Biochemistry of lipopolysaccharides. p. 3-41. In D. C. Morrison and J. L. Ryan (ed.), Bacterial endotoxic lipopolysaccharides. CRC Press, Inc., Boca Raton, Fla.
231. Rietschel, E. T., T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zähringer, U. Seydel, F. Di Padova, M. Schreier, and H. Brade. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:217-225.
232. Roberts, J. A., E. N. Fussell, and M. B. Kaach. 1990. Bacterial adherence to urethial catheters. J. Urol. 144:264-269.
233. Rosenstein, I. J. M. 1986. Urinary calculi: microbiological and crystalloeraphic studies. Crit. Rev. Clin. Lab. Sci. 22:245-277.
234. Rosenstein, I. J., J. M. Hamilton-Miller, and W. Brumfitt. 1981. Role of urease in the formation of infection stones: comparison of ureases from different sources. Infect. Immun. 32:32-37.
235. Różalski, A. Unpublished data.
236. Różalski, A., B. Bartodziejska, M. Wykrota, L. Serwecińska, S. Łukomski, and K. Kotełko. 1993. Characterization of hemolytic activity of Proteus penneri. Med. Dośw. Mikrobiol. 45:79-83. (In Polish.)
237. Różalski, A., L. Brade, P. Kosma, B. J. Appelmelk, C. Krogman, and H. Brade. 1989. Epitope specificity of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re chemotype. Infect. Immun. 57:2645-2652.
238. Różalski, A., H. Dlługońska, and K. Kotełko. 1986. Cell invasiveness of Proteus mirabilis and Proteus vulgaris strains. Arch. Immunol. Ther. Exp. 34:505-511.
239. Różalski, A., and K. Kotełko. 1987. Hemolytic activity and invasiveness in strains of Proteus penneri. J. Clin. Microbiol. 25:1094-1096.
240. Różalski, A., and M. Wykrota. 1986. Some biological features of Proteus bacilli. 3. Comparison of haemolytic activity of Proteus and Serratia strains. Acta Microbiol. Pol. 35:57-59.
241. Rubin, R. H., N. E. Tolkoff-Rubin, and R. S. Cotran. 1986. Urinary tract infection, pyelonephritis and reflux nephropathy, p. 1085-1143. In B. M. Brenner and F. C. Rector (ed.), The kidney. The W. B. Saunders Co., Philadelphia, Pa.
242. Sareneva, T., H. Holthöfer, and T. K. Korhonen. 1990. Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infect. Immun. 58:3330-3336.
243. Savoia, D., P. Martineto, A. Achino, and A. Pugliese. 1983. Adhesion of Proteus species to various cell types. Eur. J. Clin. Microbiol. 2:571-576.
244. Schindler, M., and M. J. Osborn. 1979. Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry 18:4425-4430.
245. Schoolnik, G. K., D. Lark, and P. O'Hanley. 1980. Bacterial adherence and anticolonization vaccines, p. 85-102. In J. S. Remington, and M. N. Swartz (ed.), Current clinical topics in infectious diseases. McGraw-Hill Book Co., New York, N.Y.
246. Schwalbe, R. S., P. R. Verma, and W. N. Campbell. 1991. Disseminated infection caused by Proteus penneri. Clin. Microbiol. Newsl. 13:93-95.
247. Scott, T. G. 1960. The bacteriology of urinary infections in paraplegia. J. Clin. Pathol. 13:54-56.
248. Senior, B. W. 1993. The production of HlyA toxin by Proteus penneri strains. J. Med. Microbiol. 39:282-289.
249. Senior, B. W., M. Albrechtsen, and M. A. Kerr. 1987. Proteus mirabilis strains of diverse type have IgA protease activity. J. Med. Microbiol. 24: 175-180.
250. Senior, B. W., M. Albrechtsen, and M. A. Kerr. 1988. A survey of IgA protease production among clinical isolates of Proteeae. J. Med. Microbiol. 25:27-31.
251. Senior, B. W., N. C. Bradford, and D. S. Simpson. 1980. The ureases of Proteus strains in relation to virulence for the urinary tract. J. Med. Microbiol. 13:507-512.
252. Senior, B. W., and C. Hughes. 1987. Production and properties of haemolysins from clinical isolates of the Proteeae. J. Med. Microbiol. 24:17-25.
253. Senior, B. W., and D. L. Leslie. 1986. Rare occurrence of Proteus vulgaris in feces: a reason for its rare association with urinary tract infections. J. Med. Microbiol. 21:139-144.
254. Senior, B. W., L. M. Loomes, and M. A. Kerr. 1991. The production and activity in vivo of Proteus mirabilis IgA protease in infections of the urinary tract. J. Med. Microbiol. 35:203-207.
255. Senior, B. W., L. M. Loomes, and M. A. Kerr. 1991. Microbial IgA proteases and virulence. Rev. Med. Microbiol. 2:200-207.
256. Senior, B. W., P. D. P. McBride, K. D. Morley, and M. A. Kerr. 1995. The detection of raised levels of IgM to Proteus mirabilis in sera from patients with rheumatoid arthritis. J. Med. Microbiol. 43:176-184.
257. Serwecińska, L. 1992. Ph.D. thesis. University of Łódź, Łódź, Poland. (In Polish.)
258. Setia, U., I. Serventi, and P. Lorenz. 1984. Bacteremia in a long term care facility: spectrum and mortality. Arch. Intern. Med. 144:1633-1635.
259. Sharon, N., Y. Eshdat, F. J. Silverblat, and I. Ofek. 1981. Bacterial adherence to cell surface sugars. Ciba Found. Symp. 80:119-141.
260. Shimizu, T., S.-I. Akiyama, T. Masuzawa, Y. Yanagihara, K. Ikeda, T. Takahashi, H. Kondo, and K. Achiwa. 1987. Biological activities of chemically synthesized Proteus-type lipid A. Microbiol. Immunol. 31:381-386.
261. Sidorczyk, Z., W. Kaca, H. Brade, E. T. Rietschel, U. Sinwell, and U. Zähringer. 1987. Isolation and structural characterization of an 8-O-(4-amino-4-deoxy-β-L-arabinopyranosyl)-3-deoxy-D-manno-octulosonic acid disaccharide in the lipopolysaccharide of Proteus mirabilis deep rough mutant. Eur. J. Biochem. 168:269-273.
262. Sidorczyk, Z., W. Kaca, and K. Kotełko. 1975. Studies on lipopolysaccharides of Proteus vulgaris serogroups. Chemotypes of genus Proteus lipopolysaccharides. Bull. Acad. Pol. Sci. Ser. Sci. Biol. 32:603-609.
263. Sidorczyk, Z., A. Różalski, M. Deka, and K. Kotełko. 1978. Immunochemical studies on free lipid A from Proteus mirabilis. Arch. Immunol. Ther. Exp. 26:239-243.
264. Sidorczyk, Z., A. Świerzko, Y. A. Knirel, E. V. Vinogradov, A. Y. Chernyak, L. O. Kononov, M. Cedzyński, A. Różalski, W. Kaca, A. S. Shashkov, and N. K. Kochetkov. 1995. Structure and epitope specificity of the O-specific polysaccharide of Proteus penneri 12 (ATCC33519) containing the amide of D-galacturonic acid with L-threonine. Eur. J. Biochem. 230:713-721.
265. Sidorczyk, Z., A. Świerzko, E. V. Vinogradov, Y. A. Knirel, and A. S. Shashkov. 1994. Structural and immunochemical studies of O-specific polysaccharide of Proteus penneri strain 14. Arch. Immunol. Ther. Exp. 42:209-215.
266. Sidorczyk, Z., A. Świerzko, K. Zych, A. S. Shashkov, E. V. Vinogradov, and Y. A. Knirel. 1443. Immunochemical studies of O-specific polysaccharide of Proteus penneri 14 lipopolysaccharide. Med. Dośw. Mikrobiol. 45:85-87. (In Polish.)
267. Sidorczyk, Z., A. Świerzko, K. Zych, A. S. Shashkov, E. V. Vinogradov, and V. A. Knirel. 1993. Immunochemical studies of O-specific polysaccharide of Proteus penneri 42 lipopolysaccharide. Med. Dośw. Mikrobiol. 45:89-92. (In Polish.)
268. Sidorczyk, Z., U. Zähringer, and E. T. Rietschel. 1983. Chemical structure of the lipid A component of the lipopolisacharide of Proteus mirabilis Re mutant. Eur. J. Biochem. 137:15-22.
269. Sidorczyk, Z., and K. Zych. 1986. Lipopolysaccharides of flagellated and nonflagellated Proteus vulgaris strains. Arch. Immunol. Ther. Exp. 34:461-469.
270. Silverblatt, F. J. 1974. Host-parasite interaction in the rat renal pelvis: a possible role of pili in the pathogenesis of pyelonephritis. J. Exp. Med. 140:1696-1711.
271. Silverblatt, F. J., and I. Ofek. 1978. Influence of pili on the virulence of Proteus mirabilis in experimental hematogenous pyelonephritis. J. Infect. Dis. 138:664-667.
272. Silverblatt, F. J., and I. Ofek. 1978. Effects of pili on susceptibility of Proteus mirabilis to phagocytosis and on adherence to bladder cells, p. 49-59. In E. H. Kass and W. Brumfitt (ed.), Infections of the urinary tract. University of Chicago Press, Chicago, Ill.
273. Smith, H. 1990. Pathogenicity and the microbe in vivo. J. Gen. Microbiol. 136:377-383.
274. Sogaard, H. C., Zimmermann-Nielsen, and K. Siboni. 1974. Antibiotic-resistant gram-negative bacilli in a urological ward for male patients during a nine-year period: relationship to antibiotic consumption. J. Infect. Dis. 130:646-650.
275. Sriwanthana, B., M. D., Island, D. Maneval, and H. L. T. Mobley. 1994. Single-step purification of Proteus mirabilis urease accessory protein UreE, a protein with a naturally occurring histidine tail, by nickel chelate affinity chromatography. J. Bacteriol. 176:6836-6841.
276. Sriwanthana, B., M. D. Island, and H. L. T. Mobley. 1993. Sequence of Proteus mirabilis urease accessory gene ure G. Gene 129:103-106.
277. Stahl, S. J., K. R. Stewart, and F. D. Williams. 1983. Extracellular slime associated with Proteus mirabilis during swarming. J. Bacteriol. 154:930-937.
278. Stintzing, G., B. Tufvesson, D. Habte, E. Back, T. Johnsson, and T. Wadström. 1977. Aetiology of acute diarrhoeal disease in infancy and childhood during the peak season in Addis-Ababa. Ethiop. Med. J. 15:141-146.
279. Sugawa, E., and H. Nikaido. 1992. Pore-forming activity of OmpA protein of Escherichia coli. J. Biol. Chem. 267:2507-2511.
280. -. Carbohydr. Res. 269:C1-C7.
281. Svanborg Eden, C., L. Hagberg, L. A. Hanson, T. Korhonen, H. Leffler, and S. Olling. 1981. Adhesion of Escherichia coli in urinary tract infection. Ciba Found. Symp. 80:161-187.
282. Svanborg Eden, C., S. Hansson, U. Jodal, G. Lidin-Janson, K. Lincoln, H. Linder, H. Lomberg, P. de Man, S. Marild, J. Martinell, K. Plos, T. Sandberg, and K. Stenquvist. 1988. Host-parasite interaction in the urinary tract. J. Infect. Dis. 167:421-426.
283. Svanborg Eden, C., P. Larsson, and H. Lomberg. 1980. Attachment of Proteus mirabilis to human urinary sediment epithelial cells in vitro is different from that of Escherichia coli. Infect. Immun. 27:804-807.
284. Swihart, K. G., and R. A. Welch. 1990. The HpmA hemolysin is more common than HlyA among Proteus isolates. Infect. Immun. 58:1853-1860.
285. Swihart, K. G., and R. A. Welch. 1990. Cytotoxic activity of the Proteus hemolysin HpmA. Infect. Immun. 58:1861-1869.
286. Taylor, J. F. 1928. B. proteus infections. J. Pathol. Bacteriol. 31:897-915.
287. Tolson, D. L., D. L. Barrigar, R. J. C. McLean, and E. Altman. 1995. Expression of a nonagglutinating fimbriae by Proteus mirabilis. Infect. Immun. 63:1127-1129.
288. Uhrin, D., J. R. Brisson, L. L. MacLean, J. C. Richards, and M. B. Perry. 1994. Application of 1D and 2D NMR techniques to the structure elucidation of the O-polysaccharide from Proteus mirabilis O57. J. Biomol. NMR 4:615-630.
289. Uphoff, T. S., and R. A. Welch. 1990. Nucleotide sequencing of the Proteus mirabilis calcium independent hemolysin genes (hpmA and hpmB) reveals sequence similarity with Serratia marcescens hemolysin genes (shlA and shlB). J. Bacteriol. 172:1206-1216.
290. Vaara, M. 1982. Agents that increase the permeability of the outer membrane. Microbiol. Rev. 56:395-411.
291. Vaara, M., T. Vaara, M. Jensen, I. Helander, M. Nurminen, E. T. Rietschel, and P. H. Mäkäla. 1981. Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett. 129:145-149.
292. Vaara, M., and P. Viljanen. 1985. Binding of polymyxin B nonapeptide to gram-negative bacteria. Antimicrob. Agents Chemother. 27:548-554.
293. Vinogradov, E. V., W. Kaca, Y. A. Knirel, A. Różalski, and N. K. Kochetkov. 1989. Structural studies of the fucose-containing O-specific polysaccharide of Proteus vulgaris O19. Eur. J. Biochem. 180:95-99.
294. Vinogradov, E. V., W. Kaca, A. Różalski, A. S. Shashkov, M. Cedzyński, Y. A. Knirel, and N. K. Kochetkov. 1991. Structural and immunochemical studies of O-specific polysaccharide of Proteus vulgaris 5/43 belonging to OX19 group (O-variants). Eur. J. Biochem. 200:195-201.
295. Vinogradov, E. V., W. Kaca, A. S. Shashkov, D. Krajewska-Pietrasik, A. Różalski, Y. A. Knirel, and N. K. Kochetkov. 1990. The structure of Proteus mirabilis O3 O-specific polysaccharide containing N-(2-hydroxyethyl)-D-alanine. Eur. J. Biochem. 188:645-651.
296. Vinogradov, E. V., D. Krajewska-Pietrasik, W. Kaca, A. S. Shashkov, Y. A. Knirel, and N. K. Kochetkov. 1989. Structure of Proteus mirabilis O27 O-specific polysaccharide containing amino acids and phosphoethanolamine. Eur. J. Biochem. 185:645-650.
297. Vinogradov, E. V., A. S. Shashkov, Y. A. Knirel, N. K. Kochetkov, A. Świerzko, and Z. Sidorczyk. 1991. The structure of Proteus penneri strain 14 O-specific polysaccharide containing D- and L-alanine. Carbohydr. Res. 219:C1-C3.
298. Vinogradov, E. V., Z. Sidorczyk, A. Świerzko, A. Różalski, E. D. Daeva, A. S. Shashkov, Y. A. Knirel, and N. K. Kochetkov. 1991. The structure of the O-specific polysaccharide chain of Proteus penneri strain 16 lipopolysaccharide. Eur. J. Biochem. 197:93-103.
299. Vinogradov, E. V., E. Thomas-Oates, H. Brade, and O. Holst. 1994. Structural investigation of the lipopolysaccharide from Proteus mirabilis R45 (Re-chemotype). J. Endotoxin Res. 1:199-206.
300. Wadström, T., A. Aust-Kettis, D. Habte, J. Holmgren, G. Meenwisse, R. Möllby, and O. Söderlind. 1976. Endotoxin-producing bacteria and parasites in stools of Ethiopian children with diarrhoeal disease. Arch. Dis. Child. 51:865-870.
301. Walz, S. E., S. K. Wray, S. I. Hull, and R. F. Hul. 1988. Multiple proteins encoded within the urease gene complex of Proteus mirabilis. J. Bacteriol. 170:1027-1033.
302. Warren, J. W. 1996. Clinical presentations and epidemiology of urinary tract infections, p. 3-27. In H. L. T. Mobley and J. W. Warren (ed.), Urinary tract infections. Molecular pathogenesis and clinical management. ASM Press, Washington, D.C.
303. Warren, J. W., D. Damron, J. H. Tenney, I. M. Hoopes, B. Deforge, and H. L. Muncie, Jr. 1987. Fever, bacteremia and death as complications of bacteriuria in women with long-term urethral catheters. J. Infect. Dis. 155:1151-1158.
304. Warren, J. W., J. H. Tenney, J. M. Hoopes, H. J. Muncie, and W. C. Anthony. 1982. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J. Infect. Dis. 146:719-723.
305. Wassif, C., D. Cheek, and R. Belas. 1995. Molecular analysis of metalloprotease from Proteus mirabilis. J. Bacteriol. 177:5790-5798.
306. Weber, G., D. Heck, R. R. Bartlett, and K. Nixdorff. 1992. Modulation of effects of lipopolysaccharide on macrophages by a major outer membrane protein of Proteus mirabilis as measured in a chemiluminescence assay. Infect. Immun. 60:1069-1075.
307. Weber, G., F. Link, E. Farber, P. G. Munder, D. Zeitter, R. R. Bartlett, and K. Nixdorff. 1993. Differential modulation of the effects of lipopolysaccharide on macrophages by a major outer membrane protein of Proteus mirabilis. J. Immunol. 151:415-424.
308. Welch, R. A. 1987. Identification of two different hemolysin determinants in uropathogenic Proteus isolates. Infect. Immun. 55:2183-2190.
309. Welch, R. A. 1990. Pore forming cytolysins of gram-negative bacteria. Mol. Microbiol. 5:521-528.
310. Welch, R. A., C. Forestier, A. Lobo, S. Pellett, W. Thomas, Jr., and G. Rowe. 1992. The synthesis and function of the Escherichia coli hemolysin and related RTX exotoxins. FEMS Microbiol. Immunol. 105:29-36.
311. Wenner, J. J., and L. F. Rettger. 1919. A systematic study of the Proteus group of bacteria. J. Bacteriol. 4:331-353.
312. Westenfelder, M., C. Galanos, and W. Marget. 1977. Role of antibodies to lipid A in nephritis induced by lipid A: a possible mechanism in the pathogenesis of chronic pyelonephritis, p. 100-104. In E. H. Kass and W. B. Brumfitt (ed.), Infection of the urinary tract. University of Chicago Press, Chicago, Ill.
313. Williams, F. D., and R. H. Schwarzhof. 1978. Nature of the swarming phenomenon in Proteus. Annu. Rev. Microbiol. 32:101-122.
314. Wilson, C., M. Corbett, and A. Ebringer. 1990. Increased isolation of Proteus mirabilis species from rheumatoid arthritis patients and healthy controls. Br. J. Rheumatol. 29(Suppl. II):99. (Abstract.)
315. Wray, S. K., S. I. Hull, R. G. Cook, J. Barrish, and R. A. Hull. 1986. Identification and characterization of a uroepithelial cell adhesion from a uropathogenic isolate of Proteus mirabilis. Infect. Immun. 54:43-49.
316. Yakubu, D. E., D. C. Old, and B. W. Senior. 1989. The haemagglutinins and fimbriae of Proteus penneri. J. Med. Microbiol. 30:279-284.
317. Zych, K., and Z. Sidorczyk. 1989. Lipopolysaccharides of Proteus penneri species novum. Carbohydr. Res. 188:105-111.